What does Dophaline do?
DOPHALINE specializes in the development and manufacturing of advanced pharmaceutical products. The company focuses on innovative solutions for healthcare, offering a range of medications and therapeutic options. DOPHALINE is committed to improving patient outcomes through research and quality assurance.
- Sectors
- Farms Wholesalers
- Activities
- Signals
-
ProfitableProfitable € 1.38M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.93MStrong equity provides a buffer against setbacks.
Low riskLow risk 62.5%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.87A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 1.51MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 2.00MPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 16.0%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2026
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
2.20M
|
€
1.35M
|
€
754K
|
€
998K
|
|
|
€
2.00M
|
€
1.17M
|
€
569K
|
€
836K
|
|
|
€
1.38M
|
€
755K
|
€
360K
|
€
472K
|
|
|
€
3.93M
|
€
3.15M
|
€
2.60M
|
€
2.24M
|
|
|
62.47%
|
67.88%
|
61.97%
|
59.28%
|
|
|
€
2.36M
|
€
1.49M
|
€
1.59M
|
€
1.54M
|
|
|
€
574K
|
€
298K
|
€
278K
|
€
668K
|
|
|
3
|
3
|
3
|
3
|
Publications 24
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Ontslagen - Benoemingen 27/12/2023
- Me. - Jaarrekening 31.03.2016, Ggk 03.09.2016, Ngl 05.09.2016 16589-0511-014 09/09/2016
- Me. - Jaarrekening 31.03.2015, Ggk 05.09.2015, Ngl 13.10.2015 15647-0522-015 19/10/2015
- Boekjaar - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 04/07/2014
- Me. - Jaarrekening 30.06.2013, Ggk 20.12.2013, Ngl 17.01.2014 14010-0570-015 27/01/2014
Frequently asked questions
Answers to the most common questions about Dophaline, based on official government data and the filed annual accounts.
What is the VAT number of Dophaline?
The VAT number of Dophaline is BE0456.858.815.
How many employees work at Dophaline?
In 2026, Dophaline employed 3.00 full-time equivalents (FTE).
When was Dophaline established?
Dophaline was founded in 28-12-1995.
What is the official address of Dophaline?
The official address of Dophaline is Langelede 27 Lochristi 9185.
What is the legal form of Dophaline?
The juridical form of Dophaline is Private limited company (BV/SRL).
What is the annual revenue of Dophaline?
The 2026 accounts of Dophaline do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Dophaline do?
DOPHALINE specializes in the development and manufacturing of advanced pharmaceutical products. The company focuses on innovative solutions for healthcare, offering a range of medications and therapeutic options. DOPHALINE is committed to improving patient outcomes through research and quality assurance.
Is Dophaline a reliable company?
Dophaline is a registered Rechtspersoon with company number 0456.858.815 and can be verified through the official CBE database.
What is the credit limit of Dophaline?
The estimated credit limit of Dophaline is €2,344,450.
Is Dophaline still active?
Dophaline currently has the status "Normal situation" and is active.